Directing Therapy in Pulmonary Arterial Hypertension Using a Target 6 Min Walk Distance
BACKGROUND: The most effective approaches to escalating advanced therapies in pulmonary arterial hypertension (PAH) are controversial.
Saved in:
Main Authors: | Nancy Rose Porhownik, Renelle Myers, Zoheir Bshouty |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2013/474703 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Addition of Sildenafil in Patients with Pulmonary Arterial Hypertension with Inadequate Response to Bosentan Monotherapy
by: Nancy R Porhownik, et al.
Published: (2008-01-01) -
Vascular Compromise and Hemodynamics in Pulmonary Arterial Hypertension: Model Predictions
by: Zoheir Bshouty
Published: (2012-01-01) -
Effect of Maintenance Azithromycin on Established Bronchiolitis Obliterans Syndrome in Lung Transplant Patients
by: Nancy R Porhownik, et al.
Published: (2008-01-01) -
Comparison of Per Cent Predicted and Percentile Values for Pulmonary Function Test Interpretation
by: Smita Pakhale, et al.
Published: (2009-01-01) -
Actual walking distance vs. Perceived walking distance: Relationship and impact on determining acceptable walking distances to stations of the Bangkok Metro
by: Maytarvut Seehamart, et al.
Published: (2025-03-01)